Lasting recovery requires rebuilding resilience at the metabolic, structural, immune, and neurologic levels
For the beneficiary to qualify, a provider must submit a prior authorization request to the program that attests the beneficiary is prescribed the requested drug to reduce excess body weight and maintain weight reduction in combination with current and ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label, and the beneficiary is at least 18 years of age with a BMI greater than or equal to 35. For beneficiaries with underlying medical conditions, the BMI threshold is lowered to 30 or 25 based on the diagnosis
KLOW initiates intracellular signaling cascades particularly AMPK phosphorylation and klotho receptor-mediated pathways that remain active long after the peptide itself has been cleared from circulation
Lipid-soluble statins, exemplified by simvastatin, lovastatin, and atorvastatin, effectively inhibit the growth and invasiveness of primary human endometrial stromal cells compared with that of pravastatin, a water-soluble statin (118)
As drug-device combinations, GLP-1 products require approval not only for the drug but also for the delivery device, adding another layer of complexity
